| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Off,Svp-r&D | Chief Scientific Off,Svp-r&D | Sr Vp-research &Development +1 more
1 company
Menzaghi Frederique Ph.d. is a Chief Scientific Off,Svp-r&D at TVRD. Recent filings cover 0 purchases and 48 sales. Those positions are worth an estimated $318K at current prices.
Our model assigns Menzaghi Frederique Ph.d. a strong insider score of 85/100, based on 7 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +64.8%.
Menzaghi Frederique Ph.d.'s largest disclosed position is in TVRD as Chief Scientific Off,Svp-r&D, worth about $318K. The recent filings there lean toward selling, a net 283,239 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 6,000 | $14.26 | $85,560.00 | -3.9% | |
| Oct 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 6,000 | $13.95 | $83,715.00 | -1.9% | |
| Sep 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 7,000 | $18.63 | $130,410.00 | -4.2% | |
| Aug 3, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 7,000 | $21.41 | $149,870.00 | -4.0% | |
| Jul 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 7,000 | $12.22 | $85,540.00 | -3.9% |